Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Dystech, an Australian enterprise, focuses on enhancing the process of reading assessments and dyslexia screenings through cutting-edge, AI-based solutions. Their platform, known as Dyscover, facilitates online evaluations across a range of reading concepts such as phonics, fluency, and phonological awareness, making it adaptable for both in-person and remote use. This tool is extensively utilized by professionals including speech pathologists, educators, teaching assistants, and tutors who work with children aged five and older. Upon completion of each assessment, Dyscover generates immediate and detailed reports, removing the necessity for manual grading and promoting a data-informed strategy for literacy interventions. Moreover, the AI assistant Dystutor provides tailored recommendations and lesson plans that are based on the assessment findings, thereby aiding educators in meeting the specific needs of their students. Dystech aims to revolutionize the accessibility and effectiveness of reading assessments, ultimately striving to enhance literacy outcomes for learners. By leveraging technology, they are transforming the landscape of educational support for those facing reading challenges.
Description
Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.
API Access
Has API
No
API Access
Has API
No
Integrations
Google Meet
No
Microsoft Teams
No
Zoom
No
Pricing Details
$5.65 per month
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Dystech
Founded
2017
Country
Australia
Website
dystech.com.au
Vendor Details
Company Name
Paige
Country
United States
Website
paige.ai/